HARVARD BIOSCIENCE, INC. Payments for (Proceeds from) Other Investing Activities
HARVARD BIOSCIENCE, INC. (HBIO) reported Payments for (Proceeds from) Other Investing Activities of $250.00 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-03-17.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2021-03-17
- HARVARD BIOSCIENCE, INC. payments for (proceeds from) other investing activities for the quarter ending 2020-12-31 was $250.00K.
- HARVARD BIOSCIENCE, INC. payments for (proceeds from) other investing activities for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. payments for (proceeds from) other investing activities for the quarter ending 2019-12-31 was $0.00.
- HARVARD BIOSCIENCE, INC. payments for (proceeds from) other investing activities for the quarter ending 2019-09-30 was $6.00K.
- HARVARD BIOSCIENCE, INC. payments for (proceeds from) other investing activities for fiscal 2020 was $250.00K, a 1566.67% increase from fiscal 2019.
- HARVARD BIOSCIENCE, INC. payments for (proceeds from) other investing activities for fiscal 2019 was $15.00K, a 6.25% decline from fiscal 2018.
- HARVARD BIOSCIENCE, INC. payments for (proceeds from) other investing activities for fiscal 2018 was $16.00K.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|---|
| 2020-12-31 | $250.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | $250.00K derived: sum of 2 quarters · filed 2021-03-17 | $250.00K 10-K/A · filed 2021-03-17 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | |||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | $6.00K derived: sum of 2 quarters · filed 2021-03-17 | $6.00K derived: sum of 3 quarters · filed 2021-03-17 | $15.00K 10-K/A · filed 2021-03-17 |
| 2019-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $6.00K derived: sum of 2 quarters · filed 2020-11-06 | $15.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $9.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $9.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $16.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |